| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.1M | +341.5% |
| R&D Expense | $127.7M | +15.0% |
| SG&A Expense | $63.4M | +10.6% |
| Operating Income | -$164.0M | -1.1% |
| Pre-tax Income | -$163.0M | -3.6% |
| Income Tax | $2.5M | +215.7% |
| Net Income | -$165.5M | -4.7% |
| EPS (Basic) | -$0.17 | +0.0% |
| EPS (Diluted) | -$0.17 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $108.0M | -28.0% |
| Accounts Receivable | $7.4M | +888.7% |
| Current Assets | $255.4M | -38.5% |
| Total Assets | $328.9M | -30.0% |
| Current Liabilities | $64.5M | +3.1% |
| Total Liabilities | $247.0M | -6.3% |
| Stockholders' Equity | $81.9M | -60.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$141.8M | -1421.4% |
| Capital Expenditures | $29.5M | +244.0% |
| Investing Cash Flow | $89.1M | +17.6% |
| Financing Cash Flow | $12.9M | +291.3% |
| Free Cash Flow | -$171.3M | -8047.3% |
| +0.0% |